SYNACT — SynAct Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK908.29m
- SEK894.99m
Brief: SynAct Pharma To Buy Back Own Shares
Brief: SynAct Pharma Board, Management Enter Lock-Up Agreements
Brief: Synact Pharma Management, Chairman Have Acquired Shares
Brief: SynAct Pharma Q3 Sales SEK 0
Brief: Synact Pharma Proposes EGM For Share Acquisition Authorization
Brief: Synact Pharma CFO Bjorn Westberg Leaves Company
Brief: SynAct Pharma Q2 Sales SEK 0
Brief: Synact Pharma Gets SEK 17.7 Mln After Second Warrant Conversion
Brief: SynAct To Get SEK 17.7 Mln After Conversion Of Warrants
Brief: Synact Pharma Board, Management Buy Shares Worth Over SEK 1 Mln
Brief: Synact Pharma Shares In Directed Issue At Subscription Price Of SEK 16 Per Share
Brief: SynAct Pharma Takes Out Credit Facility Of SEK 30 Million
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: Synact Gets Patent Term Adjustment for Resomelagon Therapy
Brief: SynAct Receives Notice Of Allowance For Grant Of U.S. Patent
Brief: Synact Pharma: USPTO Issues Patent For Syntact's Resomelagon Crystal Form
Brief: SynAct Pharma Q4 Sales SEK 0
Brief: SynAct Pharma Resolves On Directed Share Issue Of 227,203 Shares
Brief: Synact Pharma Announces Outcome Of Directed Share Issues